Member Info for drshaggy

Absorption through the skin, like through the lungs, oral mucosa or rectum, means that CBD (or THC) can be absorbed into the system without having to go through the gastric route and then on through the liver - which results in a marked loss/reduced dosage and so is more inefficient than the other methods of delivery. That's why GWP have gone down the oral mucosa delivery route, Zynerba transdermal patches, because the gastrointestinal route can't offer the kind of 'precise' dosage parameters demanded by the regulatory authorities. That's why Sativex is formulated as a oral buccal spray - to avoid dosage loss In the medical marijuana community precise dosage isn't an issue, so cannabis oil extracts are usually taken orally, the sheer quantity of cannabinoids overcoming the inefficiencies of absorption through the GI and liver. People who use the same cannabis oil in the form of suppositories get a much higher proportion of the dose than those who simply swallow it. I don't think that CBD is secretly psychoactive, so I don't think you have anything to worry about there.

Today's FCA update indicate that they reduced to 0.48% as of Monday 21st and are now below the reporting threshold.

Not quite sure what you mean in that first question. I've not come across the CBD/THC conversion in the gut theory before, so I've no idea about that tbh king.

Given that GWP and other regulators have been emphasising that CBD is non-psychoactive, it would be difficult for the UK authorities to turn around and say that it is psychoactive after all. And given that CBD is a naturally-occurring compound in all hemp food products, it would be hard to see how they could stop its production and use here in the UK. The police, customs and judiciary will have enough problems trying to police the ludicrously bad Psychoactive Substance Act (2016) as it is, without trying to add to their difficulties by trying to include an acknowledged non-psychoactive substance within that definition. Hemp products aren't banned in the UK in the same way they are in many US states. That might give GWP some protection in the US but not here and in much of the rest of the world.

Oxford Asset's short is up to 0.92% as of 17th March, and has now been joined by Partner Fund Management LP who were 0.57% on the same date (all this according to today's FCA short update). Trading range for that day was 405-435. Like Oxford Asset, Partner Fund probably began increasing their short on the day before the 17th (judging from the volumes on those two days) when the range was wider (411-515). With their combined hft skills I reckon they'll churn this one up and down a bit over the next few weeks, trying to push this gradually lower. Given the price that Oxford Asset initially opened their short was c.282 and below, they're going to need to push quite a bit if they're to recover that one. All IMO of course.

... reduced their short slightly from 0.71% down to 0.68% on newsday Monday, but have since increased the short again up to 0.83% on Wednesday (according to today's FCA update). I suspect that over the past couple of days they've been increasing it further.. They'll be churning this like crazy, selling, dropping the price, buying back, re-selling, over and over, skimming profit all the time using the hf trading. All IMHO of course.

PS: sorry that should have read 'down from 0.68% to 0.51%'.

Today's FCA update indicates that they decreased their short on Blinkx, as of the 10th of March, down from 0.61% to 0.51%.

At least they haven't released a negative interim trading update this time. Not yet anyway...

If the large trades today were JP Morgan covering, then I reckon we'll see the price go back down to 20p next week so they can do it all over again until they're finally gone. You get by with a little help from your friends as the song says...

Looks like JPMorgan might still be unwinding their short today. We'll see Wednesday/Thursday time I guess.

Today's update shows it's now down to 0.68% as of 26th January.

... indicates that JPMorgan Assets reduced their Blinkx short on 25th January, down from O.84% to 0.77%. Moving in the right direction IMO.

Sorry that should read 'BLNX Share News' above.

The link is from the BLNX Sahr News link in the console above this board Shroder.

My thoughts as well.

PS: it doesn't help that Citi have downgraded Blinkx from Buy to Neutral, a strange re-rating given the positive update last week. Or perhaps it does help someone, JPMorgan for example..

I suspect that the drop yesterday, today and probably early next week might be followed by a second buying spree by JPMorgan, somewhat similar to the increase we saw when they reduced their short by 0.10% last week. Looks like MM's helping their friends check out with maximum profit to me.

Me too rusty. It's been a long wait.

Same here, but pleased that, for once, the outlook is more promising.